All lobbying filings
Agios Pharmaceuticals
Agios Pharmaceuticals filed a Q3 report for Agios Pharmaceuticals on October 19, 2026.
Lobbying for Agios Pharmaceuticals · Pharmacy, Medicare/Medicaid, Health Issues
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Expenses
$30,000
What this organization spent lobbying with its own staff.
Reported using the LDA's own definitions (method A): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Government bodies contacted
2
Lobbying activity
3
Sickle Cell Policy Biotech Innovation
Biotech Innovation
Medicaid Reform